Single-Chamber Leadless Cardiac Pacemaker in Patients Without Atrial Fibrillation: Findings From Campania Leadless Registry.
atrial fibrillation
atrioventricular block
complications
effectiveness
leadless pacemaker
safety
sinus node dysfunction
syncope
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2021
2021
Historique:
received:
22
09
2021
accepted:
24
11
2021
entrez:
31
1
2022
pubmed:
1
2
2022
medline:
1
2
2022
Statut:
epublish
Résumé
Little is known about the clinical performance of single-chamber leadless pacemaker (LLPM) in patients without atrial fibrillation (AF) as pacing indication. The aim of this study was to describe the clinical characteristics of patients who underwent single chamber LLPM implantation at three tertiary referral centers and to compare the safety and effectiveness of the single-chamber LLPM among patients with or without AF. All the consecutive patients who underwent LLPM implantation at three referral centers were analyzed. The indications to LLPM in a real-world setting were described. The study population was divided into two groups according to AF as pacing indication. We assessed the procedure-related complications; moreover, we compared syncope, cardiac hospitalization, pacemaker syndrome, and all-cause death recurrence during the follow-up between patients with and without AF as pacing indication. A total of 140 consecutive patients (mean age, 76.7 ± 11.24 years, men 64.3%) were included in the study. The indication to implantation of LLPM was permanent AF with slow ventricular response ( Our real-world data suggest that LLPM may be considered a safe and reasonable treatment in patients without AF in need of pacing. Further studies are needed to confirm these preliminary results.
Identifiants
pubmed: 35097002
doi: 10.3389/fcvm.2021.781335
pmc: PMC8795374
doi:
Types de publication
Journal Article
Langues
eng
Pagination
781335Informations de copyright
Copyright © 2022 Russo, D'Andrea, De Vivo, Rago, Manzo, Bocchetti, Papa, Giordano, Ammendola, Sarubbi, Golino, D'Onofrio and Nigro.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Europace. 2019 Nov 1;21(11):1686-1693
pubmed: 31681964
N Engl J Med. 2002 Jun 13;346(24):1854-62
pubmed: 12063369
Heart Rhythm. 2017 May;14(5):702-709
pubmed: 28192207
Europace. 2020 May 1;22(5):833-838
pubmed: 32073116
Heart Rhythm. 2017 Sep;14(9):1375-1379
pubmed: 28502871
Europace. 2013 Jan;15(1):66-70
pubmed: 23097224
Europace. 2020 Apr 1;22(4):667-673
pubmed: 31960027
Heart Rhythm. 2017 Dec;14(12):1801-1806
pubmed: 28713024
N Engl J Med. 2005 Jul 14;353(2):145-55
pubmed: 16014884
J Am Heart Assoc. 2021 Jul 6;10(13):e019212
pubmed: 34169736
JACC Clin Electrophysiol. 2020 Jan;6(1):94-106
pubmed: 31709982
N Engl J Med. 2016 Feb 11;374(6):533-41
pubmed: 26551877
Circulation. 2019 Aug 20;140(8):e382-e482
pubmed: 30586772
Circulation. 2003 Jun 17;107(23):2932-7
pubmed: 12782566
Arrhythm Electrophysiol Rev. 2015 May;4(1):53-7
pubmed: 26835101